General News

Metabolomics Market 2019 Demand Status, Size, Share, Business Plans, New Technologies, Types, Applications, and Forecast by Growth Rate till 2024


The “Metabolomics Market” Report 2019-2024 has adopted a systematic way to evaluate the dynamics of the overall market. Metabolomics Market reports offers detailed assessment of the Metabolomics including enabling technologies, key trends, market drivers, challenges, market landscape, opportunities and competitor strategies.

Ask for Sample PDF of Metabolomics Market Report @

Market Overview:

  • The metabolomics market was valued at USD 1,637.43 million in 2018, and is expected to reach USD 3,565.82 million by 2024. It is estimated to register a CAGR of 13.85%, during the forecast period (2019-2024).
  • The high growth rate for this market is primarily due to its high demand in scientific communities for better analysis of diseases, biological processes, and growing applications in healthcare. There are a growing number of research universities collaborating with companies in developed markets, which use a combination of separation and detection techniques, such as GC-MS, for metabolite profiling of large sets of drugs for diagnosis and treatment of several chronic diseases, like diabetes mellitus. These researches are often recognized at the national level, and governments with private equity partners provide funds for more research toward drug discovery, biomarkers, and other related studies.

    Metabolomics Market Covers the Following Manufacturers:

  • Agilent Technologies
  • Bio
  • Rad Laboratories Inc.
  • Bruker Corporation
  • Danaher Corporation (SCIEX)
  • LECO Corporation
  • Shimadzu Corporation
  • Thermo Fisher Scientific
  • Waters Corporation
  • PerkinElmer Inc.
  • Kore Technology Limited

    Have Any Query? Ask Our Industry Experts @

    Key Market Trends:

    Biomarker and Drug Discovery Segment, under Application, is Expected to Hold the Highest Revenue

    The biomarket and drug discovery segment, under application, is projected to record a CAGR of 13.4%, over the forecast period.

    Metabolomics focus mainly on profiling small-molecule metabolites (metabolic profiling), and differ from genomics and proteomics, which characterize the profiles of genes and proteins, respectively. Additionally, biomarkers are the objective and quantitatively-measurable indicators of biological or pathogenic processes. Both metabolomics and biomarkers are progressively used in drug discovery and development, managing disease progression, especially for the personalized or precision medicine. Metabolomics and biomarkers are likely to advance the drug development and personalized therapy in the future, mainly in highly demanding disease areas, such as cardiovascular and metabolic diseases, cancer, mental health, and other infectious diseases. The increasing challenges faced by the pharmaceutical industry, such as dwindling discovery pipelines, limited budget sanctioned for a particular R&D, increasing regulatory control, significant gaps in the future drug markets, are expected to drive growth of the market.

    North America Dominates the Market and is Expected to do Same during the Forecast Period

    North America is expected to dominate the market, over other regions, throughout the forecast period. The presence of high per capita healthcare expenditure, increasing adoption rate of healthcare technology, well-established direct sales channel across the region, and continuous boost to small and mid-sized metabolomics-oriented research communities and companies, globally, from the National Institutes of Health (NIH) program, help in the growth of metabolomics business.

    Ask For Discount @

    Scope of the Report:

  • Metabolomics represent a systematic study of unique chemical processes inside the cells, which involve metabolites. The collection of entire metabolites in a biological cell, tissue, organ, or organism is called metabolome, which are the end products of cellular processes. In the past one decade, the scientific communities across the world have been integrating proteomic, transcriptomic, and metabolomic information, which helps in the early analysis of any chronic genetic or infectious diseases. These are funded by several private and public funding, which helps in the growth of the metabolomics market.

    Important Points Covered in Metabolomics Market Report:

    • Metabolomics market gives assessments for the regional level analysis with Production, Consumption, Imports, and Exports.
    • Metabolomics market forecasts for a minimum of five years of all the mentioned segments.
    • Metabolomics market shares drivers, constraints, opportunities, threats, challenges, investment opportunities.
    • Share constraints for the new entrants in Metabolomics market
    • Include manufacturing process, suppliers, price, production and consumption analysis.

    This report covers the following questions:

    • What are the difficulties to showcase development?
    • What will the market estimate be in 2024 and what will the improvement rate be?
    • Who are the major key venders in this market space?
    • What are the drivers and opportunities of Metabolomics market?

    Price of Report: $ 4250 (Single User License)

    Purchase Metabolomics Market Report @

    Metabolomics Market Covers Following Points in TOC:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Demand for Personalized Medicines
    4.2.2 High Investments by Public and Private Sectors in the Field of Metabolomics
    4.2.3 Rising Need for Early and Accurate Diagnosis of Diseases
    4.3 Market Restraints
    4.3.1 High Cost of Tools and Instruments
    4.3.2 Lack of Skilled Professionals
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 By Metabolite Analysis
    5.1.1 Analytical Techniques Separation Techniques Liquid Chromatography Gas Chromatography Capillary Electrophoresis Detection Techniques Mass Spectrometry Nuclear Magnetic Resonance Spectroscopy Other Detection Techniques
    5.1.2 Bioinformatics Tools and Database
    5.2 By Application
    5.2.1 Biomarker and Drug Discovery
    5.2.2 Toxicology
    5.2.3 Nutrigenomics
    5.2.4 Personalized Medicine
    5.2.5 Other Applications
    5.3 Geography
    5.3.1 North America United States Canada Mexico
    5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
    5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.3.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Agilent Technologies
    6.1.2 Bio-Rad Laboratories Inc.
    6.1.3 Bruker Corporation
    6.1.4 Danaher Corporation (SCIEX)
    6.1.5 LECO Corporation
    6.1.6 Shimadzu Corporation
    6.1.7 Thermo Fisher Scientific
    6.1.8 Waters Corporation
    6.1.9 PerkinElmer Inc.
    6.1.10 Kore Technology Limited


    About Industry Research:

    Industry Research is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Organization: Industry Research

    Phone: +44 20 3239 8187 / +14242530807

    Email: [email protected]

    Our latest Report: Plant Growth Hormone Market -2025 by Increasing Growth, Gross Margin and Market Share by Types